Vidmantas Petraitis

Comparative Efficacy and Distribution of Lipid Formulations of Amphotericin B in Experimental<i>Candida albicans</i>Infection of the Central Nervous System

Andreas H. Groll, Neelam Giri, Vidmantas Petraitis et al. · The Journal of Infectious Diseases · 2000 · 371 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Experimental Pulmonary Aspergillosis Due to<i>Aspergillus terreus:</i>Pathogenesis and Treatment of an Emerging Fungal Pathogen Resistant to Amphotericin B

Thomas J. Walsh, Vidmantas Petraitis, Rūta Petraitienė et al. · The Journal of Infectious Diseases · 2003 · 255 citations

Life Sciences, Infectious Diseases, Microbiology +17

Combination Therapy in Treatment of Experimental Pulmonary Aspergillosis: Synergistic Interaction between an Antifungal Triazole and an Echinocandin

Vidmantas Petraitis, Rūta Petraitienė, Alia A. Sarafandi et al. · The Journal of Infectious Diseases · 2003 · 234 citations

Medicine, Infectious Diseases, Pharmacology +17

The Pharmacokinetics and Pharmacodynamics of Micafungin in Experimental Hematogenous<i>Candida</i>Meningoencephalitis: Implications for Echinocandin Therapy in Neonates

William Hope, Diana Mickiene, Vidmantas Petraitis et al. · The Journal of Infectious Diseases · 2007 · 182 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Antifungal Efficacy of Caspofungin (MK-0991) in Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits: Pharmacokinetics, Drug Disposition, and Relationship to Galactomannan Antigenemia

Rūta Petraitienė, Vidmantas Petraitis, Andreas H. Groll et al. · Antimicrobial Agents and Chemotherapy · 2002 · 181 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17